Mauna Kea Technologies SAS

ALMKT · PA · Healthcare / Medical Devices

0.0923EUR+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.0923

Open0.0923

Day Range0.092 – 0.0954

52-Week Range0.0692 – 0.2315

Volume75.16K

Market Cap24.67M

P/E (TTM)1.24

Forward P/E55.25

EPS0.10

Dividend Yield0.00%

Beta0.94

50-Day Avg0.1524

200-Day Avg0.1566

About

Mauna Kea Technologies SA manufactures and sells medical devices in Europe, Middle East, Africa, the United States, Canada, and Asia. It offers a range of medical devices for gastroenterology, pulmonology, and urology applications. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform that enables physicians to monitor disease progression over time, assess reactions as they occur, classify areas of uncertainty, and guide surgical procedures, and help diagnose and treat patients. The company was incorporated in 2000 and is headquartered in Paris, France.

Company Details

SectorHealthcare
IndustryMedical Devices
CEOMr. Alexandre Loiseau Ph.D.
Employees59
Headquarters9, rue d'Enghien, Paris, France, 75010, France
Websitehttps://www.maunakeatech.com

Leadership

Mr. Alexandre Loiseau Ph.D.Co-Founder, CEO & Chairman
Mr. Come de La Tour du PinChief Financial Officer
Ms. Nathalie LecoqChief Operating Officer
Mr. François Lacombe Ph.D.Chief Scientific Officer
Mr. Daryl DonatelliPresident of U.S. & Head of Global Marketing

Financials

Income Statement

Currency: EUR	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	4.31M	4.05M	4.05M	5.02M	8.81M	9.98M	11.02M	8.55M	8.79M	6.69M	6.76M	8.51M	6.53M	7.70M	7.48M	11.03M	7.66M	8.22M
Growth (%)	-	-5.92%	-0.14%	+23.86%	+75.65%	+13.25%	+10.41%	-22.41%	+2.81%	-23.90%	+1.09%	+25.87%	-23.30%	+17.99%	-2.87%	+47.44%	-30.58%	+7.43%
Cost of Revenue	10.21M	1.12M	1.41M	1.58M	2.71M	3.04M	3.67M	2.53M	2.72M	2.32M	2.12M	2.53M	2.89M	1.99M	3.57M	2.10M	1.22M	2.03M
Gross Profit	-	-	2.64M	3.43M	6.11M	6.93M	7.34M	6.01M	6.07M	4.36M	4.64M	5.98M	3.63M	5.71M	3.91M	8.93M	6.44M	6.20M
Gross Margin	-	-	65.26%	68.42%	69.30%	69.51%	66.64%	70.35%	69.05%	65.26%	68.68%	70.29%	55.68%	74.17%	52.28%	80.98%	84.13%	75.33%
Operating Expense	-	-	6.63M	11.56M	19.07M	18.46M	21.16M	18.74M	16.06M	14.07M	16.64M	19.01M	17.01M	17.93M	13.52M	7.70M	12.49M	11.39M
Operating Income	-	-	-3.99M	-8.13M	-12.97M	-11.52M	-13.82M	-12.73M	-9.99M	-9.71M	-11.99M	-13.03M	-13.38M	-12.22M	-9.61M	1.23M	-6.05M	-5.20M
Operating Margin	-	-	-98.56%	-162.06%	-147.21%	-115.48%	-125.47%	-148.89%	-113.68%	-145.19%	-177.43%	-153.11%	-204.95%	-158.68%	-128.55%	11.16%	-79.02%	-63.18%
EBITDA	-	-	-3.42M	-7.06M	-12.35M	-10.85M	-12.94M	-11.95M	-9.06M	-8.75M	-10.74M	-13.98M	-11.43M	-11.23M	-9.93M	-1.46M	-7.97M	12.87M
EBITDA Margin	-	-	-84.36%	-140.69%	-140.12%	-108.70%	-117.45%	-139.85%	-103.11%	-130.90%	-158.91%	-164.34%	-175.10%	-145.87%	-132.79%	-13.25%	-104.08%	156.46%
Net Income	-	-	-3.89M	-7.93M	-13.06M	-11.52M	-13.99M	-12.64M	-9.74M	-10.24M	-13.22M	-15.27M	-12.79M	-13.45M	-11.18M	-3.73M	-10.40M	10.77M
Net Income Margin	-	-	-96.12%	-158.19%	-148.20%	-115.43%	-127.01%	-147.92%	-110.89%	-153.21%	-195.52%	-179.48%	-196.00%	-174.61%	-149.49%	-33.80%	-135.91%	130.99%
R&D	-	2.19M	1.83M	2.30M	3.26M	3.61M	4.58M	4.65M	4.45M	21.00K	3.00K	3.16M	3.23M	3.31M	4.07M	3.86M	3.55M	3.39M
R&D as % of Total Revenue	-	53.88%	45.26%	45.85%	37.03%	36.19%	41.60%	54.38%	50.59%	0.31%	0.04%	37.14%	49.52%	42.99%	54.39%	35.00%	46.37%	41.25%
Interest Expense	0	0	0	0	0	0	0	0	0	0	481.00K	597.00K	49.00K	27.00K	1.80M	270.00K	457.00K	994.00K
Interest Expense % of Total Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	7.12%	7.02%	0.75%	0.35%	24.01%	2.45%	5.97%	12.09%

Balance Sheet

Currency: EUR	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	19.36M	14.45M	11.94M	60.30M	49.06M	39.54M	27.54M	22.50M	19.97M	27.75M	19.76M	23.62M	20.61M	24.75M	19.79M	22.94M	16.25M	13.41M
Total Liabilities	4.76M	4.04M	5.07M	8.73M	8.90M	9.38M	9.39M	8.41M	8.82M	11.00M	11.78M	23.37M	32.69M	35.08M	39.72M	40.21M	40.63M	18.23M
Total Equity	14.60M	10.41M	6.86M	51.58M	40.16M	30.16M	18.15M	14.09M	11.16M	16.74M	7.98M	253.00K	-12.08M	-10.33M	-19.92M	-17.28M	-24.39M	-4.82M
Cash	12.98M	8.06M	6.32M	51.35M	37.64M	27.79M	15.02M	10.62M	9.05M	17.45M	8.62M	9.98M	8.61M	11.87M	3.14M	7.87M	1.92M	4.97M
Total Debt	-	-	2.79M	3.72M	2.57M	2.85M	2.73M	2.25M	2.73M	6.95M	7.06M	17.41M	26.96M	28.70M	29.20M	29.77M	31.93M	12.08M
Net Debt	-	-	-3.53M	-47.62M	-35.06M	-24.94M	-12.28M	-8.37M	-6.32M	-10.50M	-1.57M	7.43M	18.36M	16.83M	26.06M	21.90M	30.01M	7.11M

Cash Flow

Currency: EUR	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-	-	-2.50M	-6.18M	-13.28M	-9.61M	-12.73M	-11.73M	-7.84M	-9.74M	-10.90M	-10.27M	-7.99M	-10.27M	-8.83M	-753.00K	-6.32M	-3.74M
Investing Cash Flow	-	-	-	-	-	-1.15M	-567.00K	-326.00K	-573.00K	-735.00K	-1.25M	-1.42M	-999.00K	-1.14M	-57.00K	-354.00K	-149.00K	-200.00K
Financing Cash Flow	8.99M	-	1.57M	53.07M	2.00K	923.00K	483.00K	7.62M	6.83M	18.91M	3.30M	13.04M	7.68M	14.65M	109.00K	5.96M	483.00K	6.95M
Capital Expenditure	0	822.00K	980.43K	1.07M	1.19M	1.15M	618.00K	363.00K	516.00K	727.00K	1.25M	1.38M	1.08M	1.10M	144.00K	382.00K	215.00K	211.00K
Free Cash Flow	-	-	-3.48M	-7.25M	-14.47M	-10.76M	-13.35M	-12.09M	-8.35M	-10.47M	-12.15M	-11.65M	-9.07M	-11.37M	-8.97M	-1.14M	-6.54M	-3.95M
FCF to OCF	-	-	139.21%	117.28%	108.97%	111.92%	104.85%	103.09%	106.58%	107.46%	111.50%	113.44%	113.53%	110.68%	101.63%	150.73%	103.40%	105.65%

Earnings

Report Date	Nov 2, 2016	Mar 23, 2017	Apr 19, 2017	Jul 26, 2017	Oct 19, 2017	Mar 26, 2018	Apr 25, 2018	Jul 25, 2018	Oct 18, 2018	Mar 20, 2019	Apr 24, 2019	Sep 23, 2019	Oct 17, 2019	Apr 28, 2020	Jul 20, 2020	Oct 19, 2020	Apr 22, 2021	Jul 22, 2021	Oct 28, 2021	Apr 21, 2022	Oct 27, 2022	Mar 23, 2023	Apr 6, 2023	Sep 28, 2023	Oct 19, 2023	Apr 25, 2024	Oct 15, 2024	Apr 30, 2025	Oct 1, 2025
EPS Estimate	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EPS Actual	0.00	0.00	0.00	-0.28	0.00	-0.20	0.00	-0.27	0.00	-0.24	0.00	-0.32	0.00	-0.28	-0.22	0.00	-0.20	-0.22	0.00	-0.15	-0.14	0.00	-0.11	0.00	0.00	0.00	-0.09	-0.07	-0.07
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	After-hours	After-hours	-	Pre-market	Pre-market	After-hours	Pre-market	After-hours	Pre-market	After-hours	-	After-hours	After-hours	After-hours	After-hours	After-hours	-	After-hours	After-hours	After-hours	After-hours	-	After-hours	Pre-market	After-hours	-	-	-	-

Key Statistics & Ratios

Market Cap24.67M

Enterprise Value36.63M

Trailing P/E1.24

Forward P/E55.25

PEG Ratio0.00

Price / Sales2.77

Price / Book128.61

EPS0.10

Book Value-0.027

Revenue (TTM)8.91M

Gross Profit (TTM)7.06M

EBITDA-4.91M

Profit Margin120.91%

Operating Margin-49.27%

Return on Equity0.00%

Return on Assets-21.90%

Shares Outstanding198.63M

Shares Float169.48M

Beta0.94

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%